| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulator activity | 2.86e-04 | 18 | 28 | 2 | GO:0035014 | |
| GeneOntologyMolecularFunction | chromatin binding | 4.72e-04 | 739 | 28 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription factor binding | 5.21e-04 | 753 | 28 | 6 | GO:0008134 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 6.21e-04 | 120 | 28 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 6.60e-04 | 1459 | 28 | 8 | GO:0000977 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 8.83e-04 | 1160 | 28 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.17e-03 | 582 | 28 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.33e-03 | 1244 | 28 | 7 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.51e-03 | 1271 | 28 | 7 | GO:0000987 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 2.19e-03 | 1356 | 28 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.58e-03 | 417 | 28 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 2.76e-03 | 1412 | 28 | 7 | GO:0000981 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 3.19e-03 | 60 | 28 | 2 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 3.30e-03 | 61 | 28 | 2 | GO:0098531 | |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 2.28e-05 | 124 | 28 | 4 | GO:0001704 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 3.59e-05 | 713 | 28 | 7 | GO:0048598 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 4.96e-05 | 750 | 28 | 7 | GO:0048729 | |
| GeneOntologyBiologicalProcess | tube development | 6.39e-05 | 1402 | 28 | 9 | GO:0035295 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 8.91e-05 | 1125 | 28 | 8 | GO:0035239 | |
| GeneOntologyBiologicalProcess | brain development | 1.17e-04 | 859 | 28 | 7 | GO:0007420 | |
| GeneOntologyBiologicalProcess | neural tube development | 1.52e-04 | 202 | 28 | 4 | GO:0021915 | |
| GeneOntologyBiologicalProcess | head development | 1.77e-04 | 919 | 28 | 7 | GO:0060322 | |
| GeneOntologyBiologicalProcess | gastrulation | 1.83e-04 | 212 | 28 | 4 | GO:0007369 | |
| GeneOntologyBiologicalProcess | cellular response to peptide | 1.85e-04 | 15 | 28 | 2 | GO:1901653 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.06e-04 | 1269 | 28 | 8 | GO:0009887 | |
| GeneOntologyBiologicalProcess | regulation of type B pancreatic cell proliferation | 3.67e-04 | 21 | 28 | 2 | GO:0061469 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 3.83e-04 | 1390 | 28 | 8 | GO:0045944 | |
| GeneOntologyBiologicalProcess | embryo development | 4.80e-04 | 1437 | 28 | 8 | GO:0009790 | |
| GeneOntologyBiologicalProcess | U2-type prespliceosome assembly | 5.23e-04 | 25 | 28 | 2 | GO:1903241 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 5.87e-04 | 516 | 28 | 5 | GO:0016055 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 5.93e-04 | 1483 | 28 | 8 | GO:0048646 | |
| GeneOntologyBiologicalProcess | signal transduction involved in regulation of gene expression | 6.57e-04 | 28 | 28 | 2 | GO:0023019 | |
| GeneOntologyCellularComponent | chromatin | 6.35e-05 | 1480 | 27 | 9 | GO:0000785 | |
| GeneOntologyCellularComponent | transcription regulator complex | 9.30e-05 | 596 | 27 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | U2 snRNP | 5.95e-04 | 28 | 27 | 2 | GO:0005686 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 1.46e-03 | 1377 | 27 | 7 | GO:0140513 | |
| GeneOntologyCellularComponent | U2-type precatalytic spliceosome | 1.97e-03 | 51 | 27 | 2 | GO:0071005 | |
| GeneOntologyCellularComponent | nuclear speck | 2.15e-03 | 431 | 27 | 4 | GO:0016607 | |
| GeneOntologyCellularComponent | precatalytic spliceosome | 2.21e-03 | 54 | 27 | 2 | GO:0071011 | |
| GeneOntologyCellularComponent | euchromatin | 3.88e-03 | 72 | 27 | 2 | GO:0000791 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 5.37e-03 | 85 | 27 | 2 | GO:0000118 | |
| GeneOntologyCellularComponent | nuclear body | 5.44e-03 | 903 | 27 | 5 | GO:0016604 | |
| GeneOntologyCellularComponent | spliceosomal snRNP complex | 6.80e-03 | 96 | 27 | 2 | GO:0097525 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 6.94e-03 | 97 | 27 | 2 | GO:0005684 | |
| GeneOntologyCellularComponent | small nuclear ribonucleoprotein complex | 8.38e-03 | 107 | 27 | 2 | GO:0030532 | |
| MousePheno | perinatal lethality | 4.12e-05 | 1130 | 23 | 9 | MP:0002081 | |
| MousePheno | reduced female fertility | 1.01e-04 | 296 | 23 | 5 | MP:0001923 | |
| MousePheno | perinatal lethality, incomplete penetrance | 1.26e-04 | 503 | 23 | 6 | MP:0011090 | |
| MousePheno | craniofacial phenotype | 1.88e-04 | 1372 | 23 | 9 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 1.88e-04 | 1372 | 23 | 9 | MP:0000428 | |
| MousePheno | abnormal pulmonary alveolar sac morphology | 2.00e-04 | 13 | 23 | 2 | MP:0010902 | |
| MousePheno | abnormal forebrain morphology | 2.01e-04 | 1072 | 23 | 8 | MP:0000783 | |
| MousePheno | abnormal head morphology | 2.73e-04 | 1120 | 23 | 8 | MP:0000432 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | 2.79e-04 | 1124 | 23 | 8 | MP:0011112 | |
| MousePheno | abnormal cerebral hemisphere morphology | 3.26e-04 | 599 | 23 | 6 | MP:0008540 | |
| MousePheno | abnormal facial morphology | 4.71e-04 | 910 | 23 | 7 | MP:0003743 | |
| MousePheno | abnormal hippocampus development | 4.83e-04 | 20 | 23 | 2 | MP:0000808 | |
| Domain | - | 7.48e-05 | 57 | 27 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 7.88e-05 | 58 | 27 | 3 | IPR013088 | |
| Domain | BAH | 1.10e-04 | 11 | 27 | 2 | SM00439 | |
| Domain | BAH | 1.10e-04 | 11 | 27 | 2 | PF01426 | |
| Domain | BAH_dom | 1.10e-04 | 11 | 27 | 2 | IPR001025 | |
| Domain | BAH | 1.10e-04 | 11 | 27 | 2 | PS51038 | |
| Domain | zf-C4 | 2.00e-03 | 46 | 27 | 2 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 2.00e-03 | 46 | 27 | 2 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 2.00e-03 | 46 | 27 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 2.00e-03 | 46 | 27 | 2 | IPR001723 | |
| Domain | ZnF_C4 | 2.00e-03 | 46 | 27 | 2 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 2.00e-03 | 46 | 27 | 2 | PS51030 | |
| Domain | - | 2.09e-03 | 47 | 27 | 2 | 1.10.565.10 | |
| Domain | HOLI | 2.18e-03 | 48 | 27 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 2.18e-03 | 48 | 27 | 2 | IPR000536 | |
| Domain | Hormone_recep | 2.18e-03 | 48 | 27 | 2 | PF00104 | |
| Domain | RRM | 3.68e-03 | 217 | 27 | 3 | SM00360 | |
| Domain | RRM_dom | 4.18e-03 | 227 | 27 | 3 | IPR000504 | |
| Domain | RRM | 4.33e-03 | 230 | 27 | 3 | PS50102 | |
| Domain | - | 5.11e-03 | 244 | 27 | 3 | 3.30.70.330 | |
| Domain | Znf_C2H2-like | 5.13e-03 | 796 | 27 | 5 | IPR015880 | |
| Domain | ZnF_C2H2 | 5.47e-03 | 808 | 27 | 5 | SM00355 | |
| Domain | Nucleotide-bd_a/b_plait | 5.96e-03 | 258 | 27 | 3 | IPR012677 | |
| Domain | - | 1.56e-02 | 679 | 27 | 4 | 3.30.160.60 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.68e-02 | 694 | 27 | 4 | IPR013087 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 3.20e-06 | 153 | 22 | 5 | M39546 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 2.51e-04 | 80 | 22 | 3 | M223 | |
| Pathway | REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM | 3.12e-04 | 17 | 22 | 2 | M48030 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 3.43e-04 | 89 | 22 | 3 | M39563 | |
| Pathway | WP_FOXA2_PATHWAY | 4.80e-04 | 21 | 22 | 2 | M42579 | |
| Pathway | WP_MRNA_PROCESSING | 9.48e-04 | 126 | 22 | 3 | M39406 | |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 1.08e-03 | 132 | 22 | 3 | M48110 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.12e-03 | 32 | 22 | 2 | MM14975 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 1.27e-03 | 34 | 22 | 2 | M39771 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 1.37e-03 | 143 | 22 | 3 | M39591 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.82e-03 | 158 | 22 | 3 | MM14791 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.93e-03 | 42 | 22 | 2 | M27272 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | CBLL1 NR4A3 SFPQ SF3B4 RERE KMT2E FOXA2 RBM33 SF3A2 SLX4 IQSEC2 | 1.01e-09 | 1203 | 28 | 11 | 29180619 |
| Pubmed | Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. | 1.02e-07 | 12 | 28 | 3 | 28798046 | |
| Pubmed | 5.28e-07 | 20 | 28 | 3 | 29412136 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 22132182 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 19535458 | ||
| Pubmed | Pdx1 expression in Irs2-deficient mouse beta-cells is regulated in a strain-dependent manner. | 1.87e-06 | 3 | 28 | 2 | 12869553 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 32433020 | ||
| Pubmed | Charting Brachyury-mediated developmental pathways during early mouse embryogenesis. | 1.87e-06 | 3 | 28 | 2 | 24616493 | |
| Pubmed | Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. | 2.04e-06 | 113 | 28 | 4 | 23403292 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 16210401 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 26861571 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 20108349 | ||
| Pubmed | Retinoic acid regulates morphogenesis and patterning of posterior foregut derivatives. | 6.24e-06 | 5 | 28 | 2 | 16806149 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 15355796 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 10748198 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 6.55e-06 | 922 | 28 | 7 | 27609421 | |
| Pubmed | Functional association of U2 snRNP with the ATP-independent spliceosomal complex E. | 9.36e-06 | 6 | 28 | 2 | 10882114 | |
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 34276786 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 22121118 | ||
| Pubmed | 9.60e-06 | 167 | 28 | 4 | 25659891 | ||
| Pubmed | 1.19e-05 | 1429 | 28 | 8 | 35140242 | ||
| Pubmed | 1.29e-05 | 180 | 28 | 4 | 24104479 | ||
| Pubmed | Dominant role of DNA methylation over H3K9me3 for IAP silencing in endoderm. | 1.31e-05 | 7 | 28 | 2 | 36123357 | |
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 12488434 | ||
| Pubmed | 1.53e-05 | 399 | 28 | 5 | 35987950 | ||
| Pubmed | Dominant and context-specific control of endodermal organ allocation by Ptf1a. | 1.74e-05 | 8 | 28 | 2 | 25371369 | |
| Pubmed | The orphan steroid receptor Nur77 family member Nor-1 is essential for early mouse embryogenesis. | 1.74e-05 | 8 | 28 | 2 | 13129926 | |
| Pubmed | 2.15e-05 | 205 | 28 | 4 | 27976729 | ||
| Pubmed | 2.80e-05 | 10 | 28 | 2 | 23109420 | ||
| Pubmed | 2.80e-05 | 10 | 28 | 2 | 27072135 | ||
| Pubmed | A novel U2 and U11/U12 snRNP protein that associates with the pre-mRNA branch site. | 2.80e-05 | 10 | 28 | 2 | 11500380 | |
| Pubmed | Recognition sequences for the GYF domain reveal a possible spliceosomal function of CD2BP2. | 2.80e-05 | 10 | 28 | 2 | 15105431 | |
| Pubmed | SOX17 links gut endoderm morphogenesis and germ layer segregation. | 2.80e-05 | 10 | 28 | 2 | 25419850 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.94e-05 | 457 | 28 | 5 | 32344865 | |
| Pubmed | Meteorin regulates mesendoderm development by enhancing nodal expression. | 3.42e-05 | 11 | 28 | 2 | 24558432 | |
| Pubmed | Revising the embryonic origin of thyroid C cells in mice and humans. | 3.42e-05 | 11 | 28 | 2 | 26395490 | |
| Pubmed | Retinoid signaling in progenitors controls specification and regeneration of the urothelium. | 3.42e-05 | 11 | 28 | 2 | 23993789 | |
| Pubmed | Foxh1 and Foxa2 are not required for formation of the midgut and hindgut definitive endoderm. | 3.42e-05 | 11 | 28 | 2 | 19896480 | |
| Pubmed | Defects of the body plan of mutant embryos lacking Lim1, Otx2 or Hnf3beta activity. | 4.10e-05 | 12 | 28 | 2 | 11291865 | |
| Pubmed | 4.76e-05 | 506 | 28 | 5 | 30890647 | ||
| Pubmed | TMEM132A regulates mouse hindgut morphogenesis and caudal development. | 4.85e-05 | 13 | 28 | 2 | 37390294 | |
| Pubmed | Epithelial cell plasticity drives endoderm formation during gastrulation. | 4.85e-05 | 13 | 28 | 2 | 34168324 | |
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 22040871 | ||
| Pubmed | A Sprouty4 reporter to monitor FGF/ERK signaling activity in ESCs and mice. | 4.85e-05 | 13 | 28 | 2 | 29964027 | |
| Pubmed | Mixl1 is required for axial mesendoderm morphogenesis and patterning in the murine embryo. | 4.85e-05 | 13 | 28 | 2 | 12117810 | |
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 23213408 | ||
| Pubmed | 5.53e-05 | 1285 | 28 | 7 | 35914814 | ||
| Pubmed | Depletion of definitive gut endoderm in Sox17-null mutant mice. | 5.65e-05 | 14 | 28 | 2 | 11973269 | |
| Pubmed | 6.10e-05 | 268 | 28 | 4 | 33640491 | ||
| Pubmed | 7.17e-05 | 100 | 28 | 3 | 24859004 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 7.18e-05 | 908 | 28 | 6 | 19274049 | |
| Pubmed | Structure of the human activated spliceosome in three conformational states. | 7.45e-05 | 16 | 28 | 2 | 29360106 | |
| Pubmed | 7.45e-05 | 16 | 28 | 2 | 23824574 | ||
| Pubmed | Dual lineage-specific expression of Sox17 during mouse embryogenesis. | 7.45e-05 | 16 | 28 | 2 | 22865702 | |
| Pubmed | 7.45e-05 | 16 | 28 | 2 | 18332127 | ||
| Pubmed | 8.44e-05 | 17 | 28 | 2 | 29915126 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 9.42e-05 | 954 | 28 | 6 | 36373674 | |
| Pubmed | 9.49e-05 | 18 | 28 | 2 | 25569111 | ||
| Pubmed | 9.49e-05 | 18 | 28 | 2 | 28854362 | ||
| Pubmed | 9.49e-05 | 18 | 28 | 2 | 14645126 | ||
| Pubmed | Pancreas-specific Cre driver lines and considerations for their prudent use. | 9.49e-05 | 18 | 28 | 2 | 23823474 | |
| Pubmed | Neurog3-dependent pancreas dysgenesis causes ectopic pancreas in Hes1 mutant mice. | 9.49e-05 | 18 | 28 | 2 | 30093553 | |
| Pubmed | 1.06e-04 | 114 | 28 | 3 | 31553912 | ||
| Pubmed | A crucial role for Arf6 in the response of commissural axons to Slit. | 1.06e-04 | 19 | 28 | 2 | 30674481 | |
| Pubmed | Post-gastrulation synthetic embryos generated ex utero from mouse naive ESCs. | 1.06e-04 | 19 | 28 | 2 | 35988542 | |
| Pubmed | Quantitative lineage analysis identifies a hepato-pancreato-biliary progenitor niche. | 1.06e-04 | 19 | 28 | 2 | 34433966 | |
| Pubmed | Dual embryonic origin of the mammalian enteric nervous system. | 1.18e-04 | 20 | 28 | 2 | 30472119 | |
| Pubmed | Math1 target genes are enriched with evolutionarily conserved clustered E-box binding sites. | 1.18e-04 | 20 | 28 | 2 | 16679559 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | 1.19e-04 | 1451 | 28 | 7 | 30550785 | |
| Pubmed | 1.30e-04 | 21 | 28 | 2 | 19345177 | ||
| Pubmed | Mechanisms of the RNA helicases DDX42 and DDX46 in human U2 snRNP assembly. | 1.30e-04 | 21 | 28 | 2 | 36797247 | |
| Pubmed | 1.30e-04 | 21 | 28 | 2 | 32494006 | ||
| Pubmed | Embryo model completes gastrulation to neurulation and organogenesis. | 1.43e-04 | 22 | 28 | 2 | 36007540 | |
| Pubmed | Stromal netrin 1 coordinates renal arteriogenesis and mural cell differentiation. | 1.43e-04 | 22 | 28 | 2 | 37823339 | |
| Pubmed | 1.43e-04 | 22 | 28 | 2 | 21896659 | ||
| Pubmed | 1.56e-04 | 23 | 28 | 2 | 19737349 | ||
| Pubmed | Dkk1 and Wnt3 interact to control head morphogenesis in the mouse. | 1.71e-04 | 24 | 28 | 2 | 18403408 | |
| Pubmed | Expression of Groucho/TLE proteins during pancreas development. | 1.71e-04 | 24 | 28 | 2 | 18778483 | |
| Pubmed | Structural and functional modularity of the U2 snRNP in pre-mRNA splicing. | 1.71e-04 | 24 | 28 | 2 | 31744343 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.72e-04 | 351 | 28 | 4 | 38297188 | |
| Pubmed | Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. | 1.85e-04 | 25 | 28 | 2 | 19786569 | |
| Pubmed | 1.85e-04 | 25 | 28 | 2 | 26494787 | ||
| Pubmed | Regulation of planar cell polarity by Smurf ubiquitin ligases. | 1.85e-04 | 25 | 28 | 2 | 19379695 | |
| Pubmed | 1.85e-04 | 25 | 28 | 2 | 9731529 | ||
| Pubmed | 1.85e-04 | 25 | 28 | 2 | 36046192 | ||
| Pubmed | 2.01e-04 | 26 | 28 | 2 | 28193997 | ||
| Pubmed | 2.01e-04 | 26 | 28 | 2 | 25446530 | ||
| Pubmed | Cripto is essential to capture mouse epiblast stem cell and human embryonic stem cell pluripotency. | 2.17e-04 | 27 | 28 | 2 | 27586544 | |
| Pubmed | Loss of LKB1 leads to impaired epithelial integrity and cell extrusion in the early mouse embryo. | 2.33e-04 | 28 | 28 | 2 | 25588837 | |
| Pubmed | TET-mediated DNA demethylation controls gastrulation by regulating Lefty-Nodal signalling. | 2.33e-04 | 28 | 28 | 2 | 27760115 | |
| Pubmed | Novel genes differentially expressed in cortical regions during late neurogenesis. | 2.33e-04 | 28 | 28 | 2 | 17614941 | |
| Pubmed | Diverse Functions of Retinoic Acid in Brain Vascular Development. | 2.33e-04 | 28 | 28 | 2 | 27445154 | |
| Pubmed | 2.47e-04 | 152 | 28 | 3 | 38360978 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.57e-04 | 154 | 28 | 3 | 16055720 | |
| Pubmed | ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. | 2.68e-04 | 30 | 28 | 2 | 18462699 | |
| Pubmed | Correct patterning of the primitive streak requires the anterior visceral endoderm. | 2.68e-04 | 30 | 28 | 2 | 21445260 | |
| Pubmed | Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. | 2.68e-04 | 30 | 28 | 2 | 17882221 | |
| Pubmed | 2.68e-04 | 30 | 28 | 2 | 24302887 | ||
| Pubmed | Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. | 2.93e-04 | 161 | 28 | 3 | 36398662 | |
| Pubmed | 3.25e-04 | 33 | 28 | 2 | 33951080 | ||
| Interaction | RNF4 interactions | CBLL1 NR4A3 SFPQ SF3B4 RERE KMT2E FOXA2 RBM33 SF3A2 SLX4 IQSEC2 | 8.78e-07 | 1412 | 27 | 11 | int:RNF4 |
| Interaction | CRNKL1 interactions | 3.41e-06 | 177 | 27 | 5 | int:CRNKL1 | |
| Interaction | GSC interactions | 5.27e-06 | 87 | 27 | 4 | int:GSC | |
| Interaction | TLE1 interactions | 8.41e-06 | 213 | 27 | 5 | int:TLE1 | |
| Interaction | HDAC1 interactions | 8.46e-06 | 1108 | 27 | 9 | int:HDAC1 | |
| Interaction | MUS81 interactions | 1.29e-05 | 109 | 27 | 4 | int:MUS81 | |
| Interaction | RBM10 interactions | 1.93e-05 | 253 | 27 | 5 | int:RBM10 | |
| Interaction | SNW1 interactions | 4.34e-05 | 747 | 27 | 7 | int:SNW1 | |
| Interaction | SART1 interactions | 5.67e-05 | 317 | 27 | 5 | int:SART1 | |
| Interaction | KDM6A interactions | 6.11e-05 | 162 | 27 | 4 | int:KDM6A | |
| Interaction | ILF2 interactions | 1.07e-04 | 590 | 27 | 6 | int:ILF2 | |
| Interaction | ZNF281 interactions | 1.30e-04 | 197 | 27 | 4 | int:ZNF281 | |
| Interaction | SIN3A interactions | 1.33e-04 | 380 | 27 | 5 | int:SIN3A | |
| Interaction | EN2 interactions | 1.56e-04 | 14 | 27 | 2 | int:EN2 | |
| Interaction | TNIP2 interactions | 1.98e-04 | 952 | 27 | 7 | int:TNIP2 | |
| Interaction | ERG interactions | 2.10e-04 | 223 | 27 | 4 | int:ERG | |
| Interaction | NUP35 interactions | 2.22e-04 | 424 | 27 | 5 | int:NUP35 | |
| Interaction | DDX17 interactions | 2.27e-04 | 426 | 27 | 5 | int:DDX17 | |
| Interaction | BUB3 interactions | 2.44e-04 | 232 | 27 | 4 | int:BUB3 | |
| Interaction | ACTC1 interactions | 2.60e-04 | 694 | 27 | 6 | int:ACTC1 | |
| Interaction | HOXA5 interactions | 2.65e-04 | 94 | 27 | 3 | int:HOXA5 | |
| Interaction | TLE5 interactions | 2.72e-04 | 443 | 27 | 5 | int:TLE5 | |
| Interaction | EYA4 interactions | 2.91e-04 | 243 | 27 | 4 | int:EYA4 | |
| Interaction | DHX40 interactions | 3.19e-04 | 249 | 27 | 4 | int:DHX40 | |
| Interaction | SNRNP200 interactions | 3.23e-04 | 460 | 27 | 5 | int:SNRNP200 | |
| Interaction | SIX3 interactions | 3.24e-04 | 20 | 27 | 2 | int:SIX3 | |
| Interaction | SALL1 interactions | 3.37e-04 | 102 | 27 | 3 | int:SALL1 | |
| Interaction | WBP4 interactions | 4.10e-04 | 109 | 27 | 3 | int:WBP4 | |
| Interaction | REST interactions | 4.58e-04 | 274 | 27 | 4 | int:REST | |
| Cytoband | 7q22.3 | 6.77e-05 | 20 | 28 | 2 | 7q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 3.21e-04 | 219 | 28 | 3 | chr7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 3.18e-03 | 137 | 28 | 2 | chr9q31 | |
| GeneFamily | Nuclear hormone receptors | 1.46e-03 | 49 | 21 | 2 | 71 | |
| GeneFamily | RNA binding motif containing | 1.83e-03 | 213 | 21 | 3 | 725 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | 3.76e-06 | 1250 | 28 | 9 | M41099 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP | 2.70e-05 | 339 | 28 | 5 | M34012 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP | 5.08e-05 | 193 | 28 | 4 | M6730 | |
| Coexpression | LEE_DIFFERENTIATING_T_LYMPHOCYTE | 5.95e-05 | 201 | 28 | 4 | M2200 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500 | 3.79e-05 | 495 | 28 | 6 | PCBC_ratio_DE_vs_SC_500 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2 | 6.99e-05 | 170 | 28 | 4 | ratio_DE_vs_SC_500_K2 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#1 | 1.16e-04 | 374 | 28 | 5 | ratio_DE_vs_SC_500_K1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-06 | 186 | 28 | 4 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-06 | 189 | 28 | 4 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | mLN-T_cell-Th17|T_cell / Region, Cell class and subclass | 6.86e-06 | 198 | 28 | 4 | efdc9515dd9fb20ef9c8ddc106d88cbdde7d6ea2 | |
| ToppCell | Severe-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.01e-04 | 145 | 28 | 3 | a24cad86509208bc7267b02ef1d1b0a25a2a7043 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 167 | 28 | 3 | 4b6853efefea5178280ba7c31facda0fbd1cc469 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.59e-04 | 169 | 28 | 3 | ec23caecbb0d969307e33e9df8499ddcd1420305 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 170 | 28 | 3 | 9bea81031cdfe45e8cddac3a3afd9ca6c331c45a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 170 | 28 | 3 | 2c5a1469e5743870e96e6c2cc92f0c5096b79f51 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Pulmonary_NE_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.62e-04 | 170 | 28 | 3 | 98d13dbd76a826e47d55553f9d11f71c043b573e | |
| ToppCell | Severe-B_naive-8|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.73e-04 | 174 | 28 | 3 | f3f8c924420f46321bd47e2b97f18c7241541599 | |
| ToppCell | systemic_lupus_erythematosus-managed|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.79e-04 | 176 | 28 | 3 | e406a05345461d23cba21c5444223c937143e96a | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.89e-04 | 179 | 28 | 3 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 184 | 28 | 3 | 886d2d9bf2fe31207f17e3edc309ef44029924e1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 184 | 28 | 3 | 936b39377eebea3961d702532779f6cd27953be7 | |
| ToppCell | facs-Brain_Myeloid-Cortex|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 184 | 28 | 3 | 17f63dd671f9ff3dd2860d8de41b05c35c095950 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 184 | 28 | 3 | fe4d3def3da4ffdea5ae6bb059f5397efd58fef3 | |
| ToppCell | facs-Bladder-nan-18m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 185 | 28 | 3 | 3e00879466e626aa8604efecfc4678d64f54dbfc | |
| ToppCell | Control-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 2.08e-04 | 185 | 28 | 3 | 520795866d44def5be3910ce8e728045c716a24d | |
| ToppCell | facs-Bladder-nan-18m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 185 | 28 | 3 | 3dc5812c961ff209f197ff4cbfb90009c0537550 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Cytotoxic_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.18e-04 | 188 | 28 | 3 | c80956649b10b7dd7540394a00fc2a0619b27e80 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 188 | 28 | 3 | 5e13725136114e42d3b59647cf25e0f3c53abb54 | |
| ToppCell | facs-MAT-Fat-18m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 188 | 28 | 3 | 7f0cda7aab442aa9511d4c35569ec2389e014a71 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 189 | 28 | 3 | e5325f1c7430b574947f8ee67e425455b60dc518 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 189 | 28 | 3 | ca657353f2b649530809c0bc057e448adc511ec1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 190 | 28 | 3 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 190 | 28 | 3 | 92456f6f7eced6e4c4371f495254a65d061c8d0b | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.25e-04 | 190 | 28 | 3 | a51405f8466fc6d4087873137472619b2e84c1da | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.25e-04 | 190 | 28 | 3 | 059beca1c92181b8ba4dcd6fc71ff7530d83d0de | |
| ToppCell | 11.5-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 2.28e-04 | 191 | 28 | 3 | c1bb3ae5c297f55cdadf5b6e53d5296389d5099e | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-04 | 191 | 28 | 3 | caed913e7ede9f8ae3af273d1ecf375de6c5e813 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.32e-04 | 192 | 28 | 3 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | facs-Diaphragm|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 192 | 28 | 3 | 486cbf9791ca619e307e8b18aa70ce22111f4f26 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Monocytes|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.35e-04 | 193 | 28 | 3 | e67e960a5312ed73c5169795cb282e431866b9c1 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.35e-04 | 193 | 28 | 3 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Lung-21m-Endothelial-venous_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.39e-04 | 194 | 28 | 3 | db7b0c77ad88f7b74d85679f1fb8ee7140ac3f62 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-04 | 194 | 28 | 3 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | droplet-Lung-21m-Endothelial-venous_endothelial-vein_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.39e-04 | 194 | 28 | 3 | 17d530982789acc5e6889b215f3d433d138a41c4 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-04 | 194 | 28 | 3 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | droplet-Lung-21m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.39e-04 | 194 | 28 | 3 | 5992b9409d5855eff2afc3acd201ccd25420d2e0 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Monocytes|metastatic_Brain / Location, Cell class and cell subclass | 2.42e-04 | 195 | 28 | 3 | dfc24ee09bdc20d8a38feb8a4cc5f6b54a032981 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.42e-04 | 195 | 28 | 3 | fa8ac154e5aebc26463ff84f0ad1038095770bc6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.42e-04 | 195 | 28 | 3 | d07a8cfecf7a54cf6274565b1649e735abb79c87 | |
| ToppCell | facs-Trachea|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 196 | 28 | 3 | 34020d6553309daa269dff05de0a8567211ea4d2 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-04 | 196 | 28 | 3 | 847b3377f463bfded046eec63cc1b547f3dc33c1 | |
| ToppCell | facs-Trachea|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-04 | 196 | 28 | 3 | 8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.50e-04 | 197 | 28 | 3 | d624f3a105b19f19a0dd253ce8de3ed13adc1f01 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.50e-04 | 197 | 28 | 3 | fd5fdc5289d681d59ff22d72e4de6e74c6c7aac6 | |
| ToppCell | tumor_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 2.50e-04 | 197 | 28 | 3 | dcce1c3dc5f3e53c368f758eb0fd5afcd86325e7 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.54e-04 | 198 | 28 | 3 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-goblet|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-04 | 198 | 28 | 3 | 9c5d7852f03468394e726c444cac92a043fc6d0e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.54e-04 | 198 | 28 | 3 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-04 | 198 | 28 | 3 | f95f38cc747fb3549a791288bf8d0518c049ac96 | |
| ToppCell | mLN-ILC|mLN / Region, Cell class and subclass | 2.57e-04 | 199 | 28 | 3 | d6c299312c747fb1b7c53644c53efc03a5fffe85 | |
| ToppCell | mLN-(3)_ILC|mLN / shred on region, Cell_type, and subtype | 2.57e-04 | 199 | 28 | 3 | 00e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60 | |
| ToppCell | Skin-Mesangial|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.57e-04 | 199 | 28 | 3 | bcb78838a91cc7828680fb413fbacdb091c5fac0 | |
| ToppCell | mLN-(3)_ILC-(30)_ILC|mLN / shred on region, Cell_type, and subtype | 2.57e-04 | 199 | 28 | 3 | 33ac6d77099076df01299be429f4ba96f2f34cc1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.57e-04 | 199 | 28 | 3 | 550590b1e9c1930cbbe9cf7a141c7aeb07413096 | |
| ToppCell | mLN-ILC-ILC|mLN / Region, Cell class and subclass | 2.57e-04 | 199 | 28 | 3 | ab09a06cdea2597e9fe4b4b304655e9de4d433f6 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.61e-04 | 200 | 28 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-03 | 88 | 28 | 2 | 142d2e00ef19c0ad011a21945bf1111271056eae | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Cytl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.92e-03 | 104 | 28 | 2 | 5d9cd14e53a2f1060e528abf6c0694be9d72c356 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-03 | 108 | 28 | 2 | ee924deacd14ea404fda80ed633960143fd474c0 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-03 | 115 | 28 | 2 | e11128262ba1e2a7053b1b6c039f1aab37d2ce27 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.72e-03 | 124 | 28 | 2 | 1483be8700eca7e2c288784a290d945d4022b17f | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-03 | 126 | 28 | 2 | c3261ea8726400de87f1c8a5a5134ba2b2884f66 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Cytl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.85e-03 | 127 | 28 | 2 | eee8e4a83f7de46807440d202d46eee7dd722001 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-03 | 130 | 28 | 2 | e5acaa9aaa22b10d11410e2c01647b31354c21ed | |
| ToppCell | NS-moderate-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.98e-03 | 130 | 28 | 2 | 1491e8975520e99c527a5b5bee64875d124f7bf4 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.21e-03 | 135 | 28 | 2 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.26e-03 | 136 | 28 | 2 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.26e-03 | 136 | 28 | 2 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.30e-03 | 137 | 28 | 2 | 03e124901a0e85b59b6882bbafab568b50907e8b | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 3.35e-03 | 138 | 28 | 2 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | moderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.35e-03 | 138 | 28 | 2 | afefa8233c67aa744e939156bc538449bf6bd05b | |
| ToppCell | facs-Lung-EPCAM-3m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-03 | 140 | 28 | 2 | 731b46e4b815a45af1d0ce7ab4d0d0324ac8798f | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.45e-03 | 140 | 28 | 2 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | facs-Lung-EPCAM-3m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-03 | 140 | 28 | 2 | b30fc389583406ee6cb55112d0f7250d1b74c88a | |
| ToppCell | facs-Lung-EPCAM-3m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-03 | 140 | 28 | 2 | 35ecd887bb7827603ef673912ba820208a6368d2 | |
| ToppCell | NS-critical-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.49e-03 | 141 | 28 | 2 | 33ad925ff7be3c682741a6328216a89f9d4033e9 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.59e-03 | 143 | 28 | 2 | 7adc34d8ad11e57950a5a258ae9bf8f52259385a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.59e-03 | 143 | 28 | 2 | d0ed8c25da1327085e042c2e03cb7503e2c52ce0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.59e-03 | 143 | 28 | 2 | 8900b92a24289204b9ec7baccc11594fec7694f1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.64e-03 | 144 | 28 | 2 | 1c118b22c2ff3a526a5207d6c9d772636ee065fd | |
| ToppCell | Epithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4) | 3.74e-03 | 146 | 28 | 2 | 4511916904c1fac252cb68e871b782207f8137b3 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Adenocarcinoma-3|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.74e-03 | 146 | 28 | 2 | e55b4acecf4e363b5afa287c747c2e58c4597f3a | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-03 | 148 | 28 | 2 | f58804d24fe524b42b5090c8658050ea4b14793e | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.84e-03 | 148 | 28 | 2 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-03 | 148 | 28 | 2 | 941bad657064b3d37cae8b66df99c1aa1098c088 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Adenocarcinoma|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.89e-03 | 149 | 28 | 2 | 92a8931a51db619fb5f0638d319c02e7838f6559 | |
| ToppCell | Control-Epithelial-PNEC|World / Disease state, Lineage and Cell class | 3.89e-03 | 149 | 28 | 2 | 02b47193621d23a50378d7905d7f85aaab686cfb | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.89e-03 | 149 | 28 | 2 | d9c47f523c75ddcd6131e45d2ffc24b970932cae | |
| ToppCell | COVID-19_Severe-B_cell|World / disease group, cell group and cell class | 3.89e-03 | 149 | 28 | 2 | 9a9fcbf7e8a6811958f3fd2d36315e19ab2b1127 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.89e-03 | 149 | 28 | 2 | f18bddc84b064f3d57a1281d5172c404d87f25da | |
| ToppCell | Control-Epithelial-PNEC|Control / Disease state, Lineage and Cell class | 3.94e-03 | 150 | 28 | 2 | d6bbbe9d06a84c3de2a2e200ed512c8e8745f987 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-4|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.94e-03 | 150 | 28 | 2 | bcb99c6fa81052556ab30f9db5875fccf1ae724b | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epi_progenitor|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.99e-03 | 151 | 28 | 2 | fce04bce66411c21cd5d4d41375f26f1f50f3348 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.10e-03 | 153 | 28 | 2 | 099382241971412f84b6feefb897360a74a41143 | |
| ToppCell | COVID-19_Severe-B_cell|COVID-19_Severe / disease group, cell group and cell class | 4.10e-03 | 153 | 28 | 2 | 701a7d92ee7b22277c8462742a530347cc6f061a | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|World / disease group, cell group and cell class (v2) | 4.10e-03 | 153 | 28 | 2 | 2b4c69f6db17927d6506a645ac058133e60b0103 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.10e-03 | 153 | 28 | 2 | 26852f3d8f80e102e24bcb90e24aac26fdc9a32c | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.57e-06 | 164 | 28 | 5 | 3852_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 2.41e-06 | 179 | 28 | 5 | 2656_UP | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 4.22e-05 | 160 | 28 | 4 | 4404_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 4.22e-05 | 160 | 28 | 4 | 5275_UP | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.43e-05 | 162 | 28 | 4 | 2658_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A | 4.43e-05 | 162 | 28 | 4 | 3771_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 4.64e-05 | 164 | 28 | 4 | 3963_UP | |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.75e-05 | 165 | 28 | 4 | 3275_UP | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; PC3; HT_HG-U133A | 4.87e-05 | 166 | 28 | 4 | 5826_UP | |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.98e-05 | 167 | 28 | 4 | 4801_UP | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 5.10e-05 | 168 | 28 | 4 | 6087_UP | |
| Drug | Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 5.10e-05 | 168 | 28 | 4 | 4365_UP | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.34e-05 | 170 | 28 | 4 | 965_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 5.46e-05 | 171 | 28 | 4 | 5026_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.53e-05 | 179 | 28 | 4 | 3630_UP | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 6.67e-05 | 180 | 28 | 4 | 1477_UP | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 7.26e-05 | 184 | 28 | 4 | 4610_DN | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 8.74e-05 | 193 | 28 | 4 | 6646_DN | |
| Drug | ICI 182,780; Down 200; 1uM; PC3; HT_HG-U133A | 8.91e-05 | 194 | 28 | 4 | 4429_DN | |
| Drug | Aconitine [302-27-2]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 8.91e-05 | 194 | 28 | 4 | 2776_UP | |
| Drug | STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A | 8.91e-05 | 194 | 28 | 4 | 6380_DN | |
| Drug | aspirin, USP; Down 200; 100uM; PC3; HT_HG-U133A | 9.09e-05 | 195 | 28 | 4 | 4428_DN | |
| Drug | troglitazone; Up 200; 10uM; PC3; HG-U133A | 9.09e-05 | 195 | 28 | 4 | 431_UP | |
| Drug | Paclitaxel [33069-62-4]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 5320_UP | |
| Drug | Esculetin [305-01-1]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 7459_UP | |
| Drug | DMEP | 9.55e-05 | 12 | 28 | 2 | CID000008344 | |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 1.00e-04 | 200 | 28 | 4 | 5454_UP | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 2.58e-04 | 131 | 28 | 3 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 2.58e-04 | 131 | 28 | 3 | C4552091 | |
| Disease | Juvenile arthritis | 2.58e-04 | 131 | 28 | 3 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 2.58e-04 | 131 | 28 | 3 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 2.82e-04 | 135 | 28 | 3 | C0087031 | |
| Disease | cervical cancer (is_implicated_in) | 3.72e-04 | 30 | 28 | 2 | DOID:4362 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 6.64e-04 | 181 | 28 | 3 | DOID:684 (is_implicated_in) | |
| Disease | interleukin 12 measurement | 1.16e-03 | 53 | 28 | 2 | EFO_0004753 | |
| Disease | Insulin Sensitivity | 1.49e-03 | 60 | 28 | 2 | C0920563 | |
| Disease | Insulin Resistance | 1.49e-03 | 60 | 28 | 2 | C0021655 | |
| Disease | dentures | 2.02e-03 | 70 | 28 | 2 | EFO_0010078 | |
| Disease | dental caries, dentures | 2.02e-03 | 70 | 28 | 2 | EFO_0003819, EFO_0010078 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.85e-03 | 301 | 28 | 3 | DOID:684 (is_marker_for) | |
| Disease | diastolic blood pressure, systolic blood pressure | 3.50e-03 | 670 | 28 | 4 | EFO_0006335, EFO_0006336 | |
| Disease | Neurodevelopmental Disorders | 3.52e-03 | 93 | 28 | 2 | C1535926 | |
| Disease | eosinophil percentage of leukocytes | 5.12e-03 | 746 | 28 | 4 | EFO_0007991 | |
| Disease | RS-warfarin measurement | 6.56e-03 | 128 | 28 | 2 | EFO_0803325 | |
| Disease | cup-to-disc ratio measurement | 7.68e-03 | 430 | 28 | 3 | EFO_0006939 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HPPPPHPAALGHGPL | 271 | Q9Y2J4 | |
| QLGGDPAPHTHPHPP | 806 | Q9P281 | |
| SHHTHPSYGPPGVPP | 646 | Q92997 | |
| HSGHTPEPPLPPVGG | 416 | Q9ULK2 | |
| HLPAGPHAHSPVPPG | 1036 | Q96EV2 | |
| LSLPPLHGLHGHPPP | 36 | P10826 | |
| HLHTHPPGPGPPLQG | 71 | Q9H607 | |
| HPALPLPPGFHPHPG | 331 | O43474 | |
| PPVPHGPHGVPGPHG | 456 | Q96AE4 | |
| HTPHSPLPPTSPHGP | 1446 | Q5JU85 | |
| PLPPTSPHGPLHASG | 1451 | Q5JU85 | |
| PAPHHHPPPHPSTGL | 1686 | Q8IZD2 | |
| GPGSQPGTHPHPHPH | 141 | P41271 | |
| PGTHPHPHPHPHPGG | 146 | P41271 | |
| HPHPHPHPGGQTPEP | 151 | P41271 | |
| CGGHGHPPGHCGPPP | 11 | C9JFL3 | |
| HGGPPVTAPPPHHYN | 411 | Q75N03 | |
| HPPLPHPLHHGPGQR | 466 | Q9Y4H2 | |
| GHGVGPHQHSGPAPP | 66 | Q9GZT9 | |
| AAHLLGPPHHPGLPP | 346 | Q9Y261 | |
| GPPHHPGLPPEAHLK | 351 | Q9Y261 | |
| SPPHPPAPSPAGGHH | 196 | Q92570 | |
| HQHQHHPPGPGQPSP | 321 | Q9H6I2 | |
| HAQPPLHGQGPPGPH | 841 | Q9P2R6 | |
| HPPAPGVHPPTSGVH | 316 | Q15428 | |
| HPPAPGVHPPAPGVH | 351 | Q15428 | |
| HPQAPGVHPQPPGVH | 401 | Q15428 | |
| PHPGGHPHSSPLAPH | 1346 | Q8IY92 | |
| GPGLSTPGGHPKPPH | 221 | P23246 | |
| GHGPPVPLTPHPSGL | 136 | Q04724 | |
| HPVGGHPAPPHPHGG | 126 | Q6ZMY9 | |
| HPAPPHPHGGPEDGS | 131 | Q6ZMY9 | |
| PGHGHSHPHPFPPGG | 286 | Q15427 | |
| PHGLGHPHAGPPGSG | 316 | Q15427 | |
| PALHDTPGAPGGHPH | 261 | Q96T25 | |
| PPPPPHPHHGSGGIS | 581 | Q14003 | |
| HPHHGSGGISPPPPI | 586 | Q14003 |